Use of Nonconcurrent Common Control in Master Protocols in Oncology Trials: Report of an American Statistical Association Biopharmaceutical Section Open Forum DiscussionRajeshwari Sridhara, Cindy Lu, Martin Posch et al.|Statistics in Biopharmaceutical Research|2021Cited by 35
Type I Error Considerations in Master Protocols With Common Control in Oncology Trials: Report of an American Statistical Association Biopharmaceutical Section Open Forum DiscussionRajeshwari Sridhara, Bruce Binkowitz, Olga Marchenko et al.|Statistics in Biopharmaceutical Research|2021Cited by 12